Clinical Edge Journal Scan

Controlling inflammation may not alleviate disability in all patients with RA


 

Key clinical point: Some patients with rheumatoid arthritis (RA) had excess disability despite low inflammation level. This persisted over 8-10 years after onset, with age, pain, and depression being significant predictors of disability, independent of inflammation.

Major finding: Nearly 30%-45% of patients with RA persistently showed excess disability over 8-10 years of follow-up, independent of their inflammation status. Patients who were older (odds ratio [OR] 1.05; 95% CI 1.02-1.09) or had higher pain (OR 1.48; 95% CI 1.23-1.78) or depression (OR 1.40; 95% CI 1.01-1.94) were more likely to have higher vs. lower disability trajectory, irrespective of their inflammation level.

Study details: Findings are from an analysis of three cohort studies including 2500 patients with RA and <24 months symptom duration who were followed-up for 8-10 years.

Disclosures: This study was supported by the UK Medical Research Council, Versus Arthritis, UK National Institute for Health Care and Research (NIHR) Manchester Biomedical Research Centre, and NIHR Nottingham Biomedical Research Centre. The authors declared no competing interests directly relevant to this manuscript .

Source: Gwinnutt JM et al. Exploring the disparity between inflammation and disability in the 10-year outcomes of people with rheumatoid arthritis. Rheumatology (Oxford). 2022 (Mar 11). Doi: 10.1093/rheumatology/keac137

Recommended Reading

Long-term use of fostamatinib may increase the risk for malignant neoplasm in RA
MDedge Rheumatology
Curcumin supplementation may improve metabolic, inflammatory, and obesity markers in women with RA
MDedge Rheumatology
Severe obesity reduces responses to TNF inhibitors and non-TNF biologics to similar extent
MDedge Rheumatology
Clinical Edge Journal Scan Commentary: RA April 2022
MDedge Rheumatology
Children with RMDs not at high risk for severe COVID-19, study finds
MDedge Rheumatology
Restrictive, vegan-based diet linked to fewer RA symptoms
MDedge Rheumatology
RA: Dosage and timing of rituximab infusion influence response to COVID-19 vaccine
MDedge Rheumatology
Frailty is dynamic and responsive to treatment in early RA
MDedge Rheumatology
Elevated adipokine levels predict early death in RA
MDedge Rheumatology
Reasons for b/tsDMARD treatment interruptions in rheumatoid arthritis
MDedge Rheumatology